Researchers from the University of Pittsburgh School of Medicine and UPMC have engineered a protein that reverses carbon monoxide (CO) poisoning in mice.
The discovery could potentially lead to the creation of the first antidote in humans to the often deadly poisoning, according to research published in Science Translational Medicine. Dr. Mark Gladwin discusses the research findings.
Learn more: www.upmc.com/media/news/co-pr.